Vermeire S - Search Results

1

Geography Influences Susceptibility to SARS-CoV-2 Serological Response in Patients With Inflammatory Bowel Disease: Multinational Analysis From the ICARUS-IBD Consortium.

Wong SY, Wellens J, Helmus D, Marlow L, Brann S, Martinez Pazos V, Weinberg A, Moran HR, McGregor C, Vermeire S, Watanabe K, Kamikozuru K, Ahuja V, Vermani S, Lindsay JO, Kingston A, Dutta U, Kaur H, Silverberg MS, Milgrom R, Chien Ng S, Mak JWY, Cadwell K, Thompson C, Colombel JF, Satsangi J; ICARUS-IBD Consortium. Wong SY, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2023 Nov 2;29(11):1693-1705. doi: 10.1093/ibd/izad097. Inflamm Bowel Dis. 2023. PMID: 37354560

2

Exclusion of linkage of Crohn's disease to previously reported regions on chromosomes 12, 7, and 3 in the Belgian population indicates genetic heterogeneity.

Vermeire S, Peeters M, Vlietinck R, Parkes M, Satsangi J, Jewell D, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2000 Aug;6(3):165-70. doi: 10.1097/00054725-200008000-00002. Inflamm Bowel Dis. 2000. PMID: 10961588

3

Familial and sporadic inflammatory bowel disease: different entities?

Peeters M, Cortot A, Vermeire S, Colombel JF. Peeters M, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2000 Nov;6(4):314-20. doi: 10.1002/ibd.3780060409. Inflamm Bowel Dis. 2000. PMID: 11149564 Review.

4

Evidence for inflammatory bowel disease of a susceptibility locus on the X chromosome.

Vermeire S, Satsangi J, Peeters M, Parkes M, Jewell DP, Vlietinck R, Rutgeerts P. Vermeire S, et al. Gastroenterology. 2001 Mar;120(4):834-40. doi: 10.1053/gast.2001.22453. Gastroenterology. 2001. PMID: 11231937

5

Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families.

Vermeire S, Peeters M, Vlietinck R, Joossens S, Den Hond E, Bulteel V, Bossuyt X, Geypens B, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2001 Feb;7(1):8-15. doi: 10.1097/00054725-200102000-00002. Inflamm Bowel Dis. 2001. PMID: 11233666

6

Chromosome 3p and inflammatory bowel disease.

Satsangi J, Vermeire S. Satsangi J, et al. Among authors: vermeire s. Gut. 2001 Sep;49(3):455. doi: 10.1136/gut.49.3.455. Gut. 2001. PMID: 11550665 Free PMC article. No abstract available.

7

The value of serologic markers in indeterminate colitis: a prospective follow-up study.

Joossens S, Reinisch W, Vermeire S, Sendid B, Poulain D, Peeters M, Geboes K, Bossuyt X, Vandewalle P, Oberhuber G, Vogelsang H, Rutgeerts P, Colombel JF. Joossens S, et al. Among authors: vermeire s. Gastroenterology. 2002 May;122(5):1242-7. doi: 10.1053/gast.2002.32980. Gastroenterology. 2002. PMID: 11984510

8

Novel biological strategies in inflammatory bowel diseases.

Vermeire S, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2004 Feb;10 Suppl 1:S44-51. doi: 10.1097/00054725-200402001-00010. Inflamm Bowel Dis. 2004. PMID: 15168831 Review. No abstract available.

9

C-reactive protein as a marker for inflammatory bowel disease.

Vermeire S, Van Assche G, Rutgeerts P. Vermeire S, et al. Inflamm Bowel Dis. 2004 Sep;10(5):661-5. doi: 10.1097/00054725-200409000-00026. Inflamm Bowel Dis. 2004. PMID: 15472532 Review.

10

Pancreatic autoantibodies in inflammatory bowel disease.

Joossens S, Vermeire S, Van Steen K, Godefridis G, Claessens G, Pierik M, Vlietinck R, Aerts R, Rutgeerts P, Bossuyt X. Joossens S, et al. Among authors: vermeire s. Inflamm Bowel Dis. 2004 Nov;10(6):771-7. doi: 10.1097/00054725-200411000-00012. Inflamm Bowel Dis. 2004. PMID: 15626896

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

865 results

Search Page